Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S C Boike

Showing results (1-10 of 31) with videos related to

Pageof 4
Sort By:
Clinical Pharmacy|November 1, 1983
Additive toxicity in patients receiving vancomycin and aminoglycosidesM J Rybak, S C Boike
Emergency Medicine Clinics of North America|December 1, 1983
Pharmacologic interventions in resuscitationS C Boike, M J Rybak
Drug Intelligence & Clinical Pharmacy|January 1, 1986
Individualized adjustment of vancomycin dosage: comparison with two dosage nomogramsM J Rybak, S C Boike
Drug Intelligence & Clinical Pharmacy|October 1, 1986
Monitoring vancomycin therapyM J Rybak, S C Boike
Clinical Pharmacy|September 1, 1982
Atenolol and chlorthalidone administered alone and in combination for essential hypertensionS C Boike, Y Durley, R B Cubberley
Drug Intelligence & Clinical Pharmacy|September 1, 1982
Treatment of pseudomonal endocarditis with high-dose aminoglycosidesM J Rybak, S C Boike, P W Bush
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|May 15, 1997
Cardiovascular effects of i.v. granisetron at two administration rates and of ondansetron in healthy adultsS C Boike, B Ilson, N Zariffa, et al.
Drug Intelligence & Clinical Pharmacy|January 1, 1983
Zomepirac-related acute renal failureS C Boike, M J Rybak, J E Tintinalli, et al.
Therapeutic Drug Monitoring|January 1, 1988
Comparison of serum sampling methods for determining vancomycin dosage regimensL M Albrecht, M J Rybak, S C Boike, et al.
Clinical Therapeutics|May 20, 1998
Use of topical corticosteroid pretreatment to reduce the incidence and severity of skin reactions associated with testosterone transdermal therapyD E Wilson, K Kaidbey, S C Boike, et al.
Pageof 4

Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
Clinical Pharmacy|November 1, 1983
Additive toxicity in patients receiving vancomycin and aminoglycosidesM J Rybak, S C Boike
Emergency Medicine Clinics of North America|December 1, 1983
Pharmacologic interventions in resuscitationS C Boike, M J Rybak
Drug Intelligence & Clinical Pharmacy|January 1, 1986
Individualized adjustment of vancomycin dosage: comparison with two dosage nomogramsM J Rybak, S C Boike
Drug Intelligence & Clinical Pharmacy|October 1, 1986
Monitoring vancomycin therapyM J Rybak, S C Boike
Clinical Pharmacy|September 1, 1982
Atenolol and chlorthalidone administered alone and in combination for essential hypertensionS C Boike, Y Durley, R B Cubberley
Drug Intelligence & Clinical Pharmacy|September 1, 1982
Treatment of pseudomonal endocarditis with high-dose aminoglycosidesM J Rybak, S C Boike, P W Bush
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|May 15, 1997
Cardiovascular effects of i.v. granisetron at two administration rates and of ondansetron in healthy adultsS C Boike, B Ilson, N Zariffa, et al.
Drug Intelligence & Clinical Pharmacy|January 1, 1983
Zomepirac-related acute renal failureS C Boike, M J Rybak, J E Tintinalli, et al.
Therapeutic Drug Monitoring|January 1, 1988
Comparison of serum sampling methods for determining vancomycin dosage regimensL M Albrecht, M J Rybak, S C Boike, et al.
Clinical Therapeutics|May 20, 1998
Use of topical corticosteroid pretreatment to reduce the incidence and severity of skin reactions associated with testosterone transdermal therapyD E Wilson, K Kaidbey, S C Boike, et al.
Pageof 4